Daniel J. Brennan

2019

In 2019, Daniel J. Brennan earned a total compensation of $4M as Executive Vice President and Chief Financial Officer at Boston Scientific, a 10% increase compared to previous year.

Compensation breakdown

Change in Pension Value and Nonqualified Deferred Compensation Earnings$190,385
Non-Equity Incentive Plan$583,482
Option Awards$587,497
Salary$655,437
Stock Awards$1,977,244
Other$37,241
Total$4,031,286

Brennan received $2M in stock awards, accounting for 49% of the total pay in 2019.

Brennan also received $190.4K of change in pension value and nonqualified deferred compensation earnings, $583.5K in non-equity incentive plan, $587.5K in option awards, $655.4K in salary and $37.2K in other compensation.

Rankings

In 2019, Daniel J. Brennan's compensation ranked 2,944th out of 13,971 executives tracked by ExecPay. In other words, Brennan earned more than 78.9% of executives.

ClassificationRankingPercentile
All
2,944
out of 13,971
79th
Division
Manufacturing
1,063
out of 5,692
81st
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
147
out of 832
82nd
Industry group
Surgical, Medical, And Dental Instruments And Supplies
79
out of 535
85th
Industry
Surgical and Medical Instruments and Apparatus
48
out of 350
86th

Pay ratio

Daniel J. Brennan's Pay$4,031,286
Median Employee's Pay$65,630
Pay Ratio

61

to 1

In 2019, the annual total compensation of Daniel J. Brennan was $4,031,286.

The annual total compensation of the median employee at Boston Scientific was $65,630.

The ratio of Daniel J. Brennan's pay to the pay of median employee was therefore 61 to one.

Source: SEC filing on March 25, 2020.

Brennan's colleagues

We found four more compensation records of executives who worked with Daniel J. Brennan at Boston Scientific in 2019.

2019

Michael Mahoney

Boston Scientific

Chief Executive Officer

2019

Joseph Fitzgerald

Boston Scientific

Executive Vice President and President, Rhythm Management

2019

Kevin Ballinger

Boston Scientific

Executive Vice President and President, Interventional Cardiology

2019

Edward Mackey

Boston Scientific

Executive Vice President, Operations

News

You may also like